What was filed
Maruti Suzuki India Limited announced its financial results for the first quarter (April–June) of FY 2026-27. Alongside the results, the Board approved four compressed biogas (CBG) manufacturing projects in a first phase, and said it would consider further CBG expansion based on the experience of these initial projects.
Volumes rose, profit fell
The quarter shows a divergence between the top and bottom lines. Total sales volume grew sharply over the same period a year earlier, helped by the commissioning of the company's second plant in Kharkhoda, and net sales rose accordingly. Domestic market share increased by 2.3 percentage points to 41.2%, with network inventory at quarter-end at only about 13 days.
Despite this, net profit declined year-on-year. Per the filing, material costs had started to increase during the quarter and were "seriously aggravated during the war" — the factor the company attributes to the profit falling even as sales grew.
A restated comparison base
The company noted that its wholly owned subsidiary Suzuki Motor Gujarat Private Limited amalgamated with Maruti Suzuki starting December 1, 2025. Because the appointed date under the scheme is April 1, 2025, the financial statements for the relevant periods have been restated for comparison, so the prior-year figures reflect the combined entity.